SIE 0.00% 6.8¢ scigen limited

re: production cost Bioshares (6 May) in its article on SIE...

  1. 7,889 Posts.
    lightbulb Created with Sketch. 251
    re: production cost Bioshares (6 May) in its article on SIE indicates that the Hep B is manufactured thru a cloning process and indicates
    a "modest capital expenditure" Sales so far have been modest $750000. I am impressed by this Company so may have a blinkered view BUT?
 
watchlist Created with Sketch. Add SIE (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.